HGF/SF in Non-Small-Cell Lung Carcinomas
Author Information
Author(s): M Olivero, M Rizzo, R Madeddu, C Casadio, S Pennacchietti, MR Nicotra, M Prat, G Maggi, N Arena, PG Natali, PM Comoglio, MF Di Renzo
Primary Institution: Institute for Cancer Research and Treatment IRCC, University of Torino Medical School
Hypothesis
We postulated that uPA might promote the invasive properties of NSCLC via HGF/SF activation.
Conclusion
HGF/SF is overexpressed and consistently activated in non-small-cell lung carcinomas and may contribute to the invasive growth of lung cancer.
Supporting Evidence
- HGF/SF was found to be 10 to 100-fold overexpressed in carcinoma samples.
- The Met/HGF receptor was found to be 2 to 10-fold increased in 25% of carcinoma samples.
- Immunohistochemical staining showed homogeneous expression of both the receptor and the ligand in carcinoma samples.
Takeaway
This study found that a protein called HGF/SF is much more active in lung cancer than in normal lung tissue, which might help the cancer grow and spread.
Methodology
Tissue samples from 42 patients were analyzed using Western blot analysis to compare HGF/SF and Met/HGF receptor expression in carcinoma and adjacent normal tissues.
Limitations
The study did not allow for statistical analysis of the correlation between overexpression and disease stage.
Participant Demographics
Mean age 65 (range 40-76) years; 37 males and 5 females.
Statistical Information
P-Value
P=0.0113
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website